Curious about what else BCC's AI Reports cover?
Get complimentary access to VerticalContext Chat.
Report Highlights
This report provides an outlook of artificial intelligence (AI) impact on the global market for monoclonal antibodies (mAbs) in oncology. It highlights major adoption trends of AI and machine learning-based algorithms across the key geographic regions from North America to the Asia-Pacific and Europe. The report covers disruptions caused across several key industry verticals and the impact on the various stages of global supply chain.
Report Includes
- Impact analysis of artificial intelligence on the global monoclonal antibodies in oncology market
- Insights of the use cases/case studies for AI implementation related to monoclonal antibodies in oncology
- Understanding of AI adoption trends across the major geographic regions
- Review of AI disruption trends across the key industry verticals
- Impact of AI on various stages of the value chain
- Analysis of the companies’ market spendings and forecasting analysis, and a VC investment outlook
Report Scope
Artificial intelligence (AI) is massively transforming the global monoclonal antibodies (mAbs) in oncology market by accelerating and de-risking the development pipeline. Deep learning (DL) and generative models enable rapid screening of molecular libraries, identifying and designing novel antibody sequences with optimized properties for drug safety and efficacy. This in silico precision reduces reliance on traditional experimental methods, reducing development time and cost. AI is also increasingly used for predictive modeling to assess an antibody’s developability and to personalize cancer treatment by predicting a patient’s response to specific mAb therapies.
Major companies operating within the monoclonal antibodies in oncology industry, including Merck & Co. Inc., F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Co., and AstraZeneca, are at the forefront of AI integration in R&D and drug manufacturing.
This report provides a global outlook of the AI impact on monoclonal antibodies in oncology. It also highlights major AI adoption and disruption trends across the regions.
Recent Reports
AI Impact on Agricultural Biotechnology - BCC Pulse Report
This report covers the AI impact on agricultural biotechnology market. It highlights key use cases for AI implementation in the sector and adoption trends of AI across different geographic regions. It also highlights how AI is reshaping key industry verticals and how companies are investing in AI for competitive advantage.
AI Impact on Diabetes - BCC Pulse Report
This report covers the impact of AI on the diabetes market. It highlights the use of AI for early risk detection, personalized treatment planning, and continuous patient monitoring. AI is also being integrated into mobile health applications and wearable devices to support diet, physical activity, medication adherence, and day-to-day diabetes management.
AI Impact on Glass Ceramics Markets - BCC Pulse Report
This report examines the impact of artificial intelligence (AI) on the global glass ceramics market, highlighting its role in material development, manufacturing efficiency and quality improvement. It also covers industry trends across different geographic regions, regional developments and competitive activity shaping the market.
AI Impact on Gene Synthesis Technologies Market - BCC Pulse Report
This report covers the AI impact on gene synthesis technologies market. It highlights key use cases for AI implementation in the sector and adoption trends of AI across different geographic regions. It also highlights how AI is reshaping key industry verticals and how companies are investing in AI for competitive advantage.
AI Impact on Intravenous (IV) Therapy and Vein Access Market- BCC Pulse Report
This report explores the impact of artificial intelligence (AI) on the intravenous (IV) therapy and vein access market, highlighting its role in improving vein access, infusion management and patient care. It also reviews technology trends, regional developments and competitive activity across the industry.
Top Trending Reports
Validation, Calibration, and Standardization in the Life Sciences Market
The global market for validation, calibration, and standardization in life sciences was valued at $2.8 billion in 2025 and is estimated to reach $3.9 billion by 2030, at a compound annual growth rate (CAGR) of 6.7% from 2025 through 2030.
Outpatient Surgical Procedures: Global Markets
The global market for outpatient surgical procedures is expected to grow from $381.9 billion in 2026 and is projected to reach $598.6 billion by the end of 2031, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2026 to 2031.
Global Markets for Fermentation Ingredients
The global market for fermentation ingredients is expected to grow from $39.8 billion in 2026 and is projected to reach $53.4 billion by the end of 2031, at a compound annual growth rate (CAGR) of 6.1% during the forecast period of 2026 to 2031.
Global Enterprise Artificial Intelligence (AI) Market
This study examines the global enterprise AI market across key segments such as component, software deployment, technology, organization size, end user and geography. It focuses on commercially deployed AI software, services and hardware generating revenue across industries, including new deployments and the expansion of existing AI infrastructure. The analysis also covers emerging technologies, major market trends and challenges, the competitive landscape and profiles of leading companies. Regional market trends are assessed using 2025 as the base year, with forecasts from 2026 through 2031.
Molecular Diagnostics: Technologies and Global Markets
The global market for molecular diagnostics is expected to grow from $23 billion in 2025 and is projected to reach $42.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.1% during the forecast period of 2025 to 2030.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More